Search research articles
Contact Us
Filters
Showing results (331-340 of 566) with videos related to
Page
of 57
Sort By:
American Journal of Hematology
|
October 13, 2016
Beta-blockers improve survival outcomes in patients with multiple myeloma: a retrospective evaluation
Yi L Hwa, Qian Shi, Shaji K Kumar, et al.
Blood
|
April 14, 2012
Clonal competition with alternating dominance in multiple myeloma
Jonathan J Keats, Marta Chesi, Jan B Egan, et al.
Blood
|
November 9, 2011
Immunoglobulin D amyloidosis: a distinct entity
Morie A Gertz, Francis K Buadi, Suzanne R Hayman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 26, 2019
Randomized Trial of Lenalidomide Versus Observation in Smoldering Multiple Myeloma
Sagar Lonial, Susanna Jacobus, Rafael Fonseca, et al.
Blood Cancer Journal
|
November 10, 2018
Bortezomib, lenalidomide, and dexamethasone (VRd) followed by autologous stem cell transplant for multiple myeloma
M Hasib Sidiqi, Mohammed A Aljama, Irbaz Bin Riaz, et al.
Blood
|
June 25, 2014
Trends in survival of patients with primary plasma cell leukemia: a population-based analysis
Wilson I Gonsalves, S Vincent Rajkumar, Ronald S Go, et al.
American Journal of Hematology
|
May 3, 2012
Trends and outcomes of modern staging of solitary plasmacytoma of bone
Rahma Warsame, Morie A Gertz, Martha Q Lacy, et al.
Haematologica
|
August 2, 2016
Immunoparesis status in immunoglobulin light chain amyloidosis at diagnosis affects response and survival by regimen type
Eli Muchtar, Angela Dispenzieri, Shaji K Kumar, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 18, 2026
Ixazomib, Cyclophosphamide, and Dexamethasone (ICd), With or Without Daratumumab in Relapsed Multiple Myeloma
Shaji Kumar, Betsy Knopf, Erik Asmus, et al.
British Journal of Haematology
|
May 10, 2026
Predictors of renal response in AL amyloidosis following anti-plasma cell therapy: The impact of baseline serum free light chain levels and light chain isotype
Matthew J Rees, Binoy Yohannan, Susan Geyer, et al.
Page
of 57
Search research articles
Search
Showing results (331-340 of 566) with videos related to
Sort By:
Page
of 57
American Journal of Hematology
|
October 13, 2016
Beta-blockers improve survival outcomes in patients with multiple myeloma: a retrospective evaluation
Yi L Hwa, Qian Shi, Shaji K Kumar, et al.
Blood
|
April 14, 2012
Clonal competition with alternating dominance in multiple myeloma
Jonathan J Keats, Marta Chesi, Jan B Egan, et al.
Blood
|
November 9, 2011
Immunoglobulin D amyloidosis: a distinct entity
Morie A Gertz, Francis K Buadi, Suzanne R Hayman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 26, 2019
Randomized Trial of Lenalidomide Versus Observation in Smoldering Multiple Myeloma
Sagar Lonial, Susanna Jacobus, Rafael Fonseca, et al.
Blood Cancer Journal
|
November 10, 2018
Bortezomib, lenalidomide, and dexamethasone (VRd) followed by autologous stem cell transplant for multiple myeloma
M Hasib Sidiqi, Mohammed A Aljama, Irbaz Bin Riaz, et al.
Blood
|
June 25, 2014
Trends in survival of patients with primary plasma cell leukemia: a population-based analysis
Wilson I Gonsalves, S Vincent Rajkumar, Ronald S Go, et al.
American Journal of Hematology
|
May 3, 2012
Trends and outcomes of modern staging of solitary plasmacytoma of bone
Rahma Warsame, Morie A Gertz, Martha Q Lacy, et al.
Haematologica
|
August 2, 2016
Immunoparesis status in immunoglobulin light chain amyloidosis at diagnosis affects response and survival by regimen type
Eli Muchtar, Angela Dispenzieri, Shaji K Kumar, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 18, 2026
Ixazomib, Cyclophosphamide, and Dexamethasone (ICd), With or Without Daratumumab in Relapsed Multiple Myeloma
Shaji Kumar, Betsy Knopf, Erik Asmus, et al.
British Journal of Haematology
|
May 10, 2026
Predictors of renal response in AL amyloidosis following anti-plasma cell therapy: The impact of baseline serum free light chain levels and light chain isotype
Matthew J Rees, Binoy Yohannan, Susan Geyer, et al.
Page
of 57